Arrayit Corporation (ARYC)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 24, 2025
Theseus Pharmaceuticals Revenue
Arrayit had revenue of $615.15K in the quarter ending September 30, 2015, with 24.86% growth. This brings the company's revenue in the last twelve months to $2.82M, down -30.53% year-over-year. In the year 2014, Arrayit had annual revenue of $4.38M with 50.83% growth.
Revenue (ttm)
2.82M
Revenue Growth
-30.53%
P/S Ratio
0.00
Revenue / Employee
402.90K
Employees
7
Market Cap
2.25K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 4.38M | 1.48M | 50.83% |
| Dec 31, 2013 | 2.90M | 410.30K | 16.47% |
| Dec 31, 2012 | 2.49M | -1.32M | -34.62% |
| Dec 31, 2011 | 3.81M | 734.61K | 23.87% |
| Dec 31, 2010 | 3.08M | -916.77K | -22.96% |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |